Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Lundbeck
Marketing
Rising Stars: Andrew Willett on bettering the world via comms
In a Q&A for Fierce Pharma Marketing’s “Rising Stars” series, Andrew Willett discussed the importance of moving quickly in comms.
John Newton
Dec 17, 2025 6:00am
With $2.37B offer, Alkermes sweetens deal to acquire Avadel
Nov 19, 2025 9:53am
Despite Alkermes deal, Avadel now prefers Lundbeck's $2.4B offer
Nov 18, 2025 12:40pm
Lundbeck looks to buy Avadel from under Alkermes with $2.25B bid
Nov 14, 2025 9:29am
Lundbeck, Otsuka back survey on Alzheimer's agitation
Nov 12, 2025 12:07pm
Celltrion buy, Rexulti CRL, Glenmark-Hengrui—Fierce Pharma Asia
Sep 26, 2025 10:00am
